23 results
424B3
IKT
Inhibikase Therapeutics Inc
4 Apr 23
Prospectus supplement
4:57pm
to be acquired by a competitor, the competitor may elect not to continue to manufacture for us at all. The loss of a supplier could cause manufacturing delays
POS AM
IKT
Inhibikase Therapeutics Inc
31 Mar 23
Prospectus update (post-effective amendment)
4:11pm
. If a manufacturer were to be acquired by a competitor, the competitor may elect not to continue to manufacture for us at all. The loss of a supplier could cause
424B4
m3xig2 2yox93m
17 Jun 21
Prospectus supplement with pricing info
4:31pm
8-K
EX-1.1
0620cm nnd3byr
16 Jun 21
Inhibikase Therapeutics Prices Follow-On Public Offering of Common Stock
9:20am
DRS
EX-1.1
pvy1ixssj
2 Jun 21
Draft registration statement
12:00am
DRS
2o1vw671h52vefrj
2 Jun 21
Draft registration statement
12:00am
10-K
re7f606
31 Mar 21
Annual report
2:14pm
424B4
96esl8nvcpot zcdrsz9
28 Dec 20
Prospectus supplement with pricing info
6:04am